MedTrace Logo

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

NCT07220967 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 392

Last updated 2026-04-09

No results posted yet for this study

Summary

The researchers are doing this study to find out whether Stimulan Rapid Cure works to reduce the risk of infections in people getting tissue expanders placed during mastectomy. The researchers will also study whether Stimulan Rapid Cure affects the risk of seroma, a possible complication of surgery that involves fluid buildup under the skin.

Conditions

Interventions

PROCEDURE

Tissue Expander (TE)

Tissue Expander (TE)

DRUG

Vancomycin and Gentamicin

Given through Stimulan Rapid Cure during surgery

DEVICE

Stimulan Rapid Cure

Vancomycin and Gentamicin given through Stimulan Rapid Cure during surgery

Sponsors & Collaborators

Principal Investigators

  • Danielle Rochlin, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-21
Primary Completion
2027-10-31
Completion
2027-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07220967 on ClinicalTrials.gov